Dual versus monotherapy with bronchodilators in GOLD group B COPD patients according to baseline FEV(1) level: a patient-level pooled analysis of phase-3 randomized clinical trials

BACKGROUND: Which patients should receive dual therapy as initial treatment for chronic obstructive pulmonary disease (COPD) is only loosely defined. We evaluated if a lower forced expiratory volume in 1 s (FEV(1)) identifies a population more likely to benefit from dual therapy than monotherapy amo...

Full description

Saved in:
Bibliographic Details
Published in:Respir Res
Main Authors: Kang, Jieun, Lee, Jae Seung, Lee, Sei Won, Lee, Jung Bok, Oh, Yeon-Mok
Format: Artigo
Language:Inglês
Published: BioMed Central 2021
Subjects:
Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7881547/
https://ncbi.nlm.nih.gov/pubmed/33579288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-021-01648-5
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items